Penn’s newly developed seven-story facility at 3600 Civic Center Boulevard will bring together labs across disciplines to advance breakthroughs in immune health, autoimmunity, and infectious diseases. E. John Wherry, PhD, Director of the Colton Consortium at Penn Medicine, discusses how this center will change how immunology research is carried out at Penn, facilitating innovations in the diagnosis, treatment and prevention of immune-related diseases through CAR T-cell therapies, mRNA treatments, and AI-driven drug discovery. Read more here.